2009/52/EC: Commission Decision of 18 December 2008 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2009 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council on substances that deplete the ozone layer (notified under document number C(2008) 8398)

1 The quantity of controlled substances of Group I (chlorofluorocarbons 11, 12, 113, 114 and 115) subject to Regulation (EC) No 2037/2000 which may be used for essential medical uses in the Community in 2009 shall be 21360,00 ozone depleting potential (ODP) kilograms.

2 The quantity of controlled substances of Group I (chlorofluorocarbons 11, 12, 113, 114 and 115) and Group II (other fully halogenated chlorofluorocarbons) subject to Regulation (EC) No 2037/2000 which may be used for essential laboratory and analytical uses in the Community in 2009 shall be 60280,8 ODP kilograms.

3 The quantity of controlled substances of Group III (halons) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory and analytical use in the Community in 2009 shall be 115,7 ODP kilograms.

4 The quantity of controlled substances of Group IV (carbon tetrachloride) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory and analytical uses in the Community in 2009 shall be 129390,8 ODP kilograms.

5 The quantity of controlled substances of Group V (1,1,1-trichloroethane) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory and analytical uses in the Community in 2009 shall be 355,65 ODP kilograms.

6 The quantity of controlled substances of Group VI (methyl bromide) subject to Regulation (EC) No 2037/2000 that may be used for laboratory and analytical critical uses in the Community in 2009 shall be 36,3 ODP kilograms.

7 The quantity of controlled substances of Group VII (hydrobromofluorocarbons) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory and analytical uses in the Community in 2009 shall be 57,96 ODP kilograms.

8 The quantity of controlled substances of group IX (bromochloromethane) subject to Regulation (EC) No 2037/2000 that may be used for essential laboratory and analytical uses in the Community in 2009 shall be 11,088 ODP kilograms.

The chlorofluorocarbon metered-dose inhalers listed in Annex I shall not be placed on markets where the competent authority has determined chlorofluorocarbons for metered-dose inhalers on those markets to be non-essential.

During the period 1 January to 31 December 2009 the following rules shall apply: 1. The allocation of essential medical use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 shall be to the companies indicated in Annex II. 2. The allocation of essential laboratory and analytical use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 and other fully halogenated chlorofluorocarbons shall be to the companies indicated in Annex III. 3. The allocation of essential laboratory and analytical use quotas for halons shall be to the companies indicated in Annex IV. 4. The allocation of essential laboratory and analytical use quotas for carbon tetrachloride shall be to the companies indicated in Annex V. 5. The allocation of essential laboratory and analytical use quotas for 1,1,1-trichloroethane shall be to the companies indicated in Annex VI. 6. The allocation of laboratory and analytical critical use quotas for methyl bromide shall be to the companies indicated in Annex VII. 7. The allocation of essential laboratory and analytical use quotas for hydrobromofluorocarbons shall be to the companies indicated in Annex VIII. 8. The allocation of essential laboratory and analytical use quotas for bromochloromethane shall be to the companies indicated in Annex IX. 9. The essential use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115, other fully halogenated chlorofluorocarbons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane and the laboratory and analytical critical use quotas for methyl bromide shall be as set out in Annex X.

This Decision shall apply from 1 January 2009 and shall expire on 31 December 2009.

This Decision is addressed to the following undertakings: Acros Organics bvba Janssen Pharmaceuticalaan 3a B-2440 Geel Airbus France 316, route de Bayonne F-31300 Toulouse Carlo Erba Réactifs-SDS Z.I. de Valdonne, BP 4 F-13124 Peypin Chiesi Farmaceutici SpA Via Palermo 26/A I-43100 Parma CNRS — Groupe de physique des solides Université Paris 7 Denis Diderot et Paris 6 Pierre et Marie Curie F-75251 Paris Cedex 5 Harp International Gellihirion Industrial Estate Rhondda, Cynon Taff Pontypridd CF37 5SX UNITED KINGDOM Honeywell Specialty Chemicals Wunstorfer Straße 40 Postfach 10 02 62 D-30918 Seelze Ineos Fluor Ltd PO Box 13, The Heath Runcorn Cheshire WA7 4QF UNITED KINGDOM Institut scientifique de service public Rue du Chéra 200 B-4000 Liège LGC Standards GmbH Mercatorstraße 51 D-46485 Wesel Mallinckrodt Baker BV Teugseweg 20 7418 AM Deventer Nederland Merck KGaA Frankfurter Straße 250 D-64271 Darmstadt Mikro + Polo d.o.o. Zagrebška cesta 22 SI-2000 Maribor Ministry of Defense Defence Fuel Lubricants and Chemicals PO Box 10 000 1780 CA Den Helder Nederland Panreac Química SA Pol. Ind. Pla de la Bruguera, C/Garraf, 2 E-08211 Castellar del Vallès Barcelona Sigma Aldrich Chimie SARL 80, rue de Luzais L’Isle d’Abeau Chesnes F-38297 Saint-Quentin-Fallavier Sigma Aldrich Company The Old Brickyard, New Road Gillingham SP8 4XT UNITED KINGDOM Sigma Aldrich Laborchemikalien Wunstorfer Straße 40 Postfach 10 02 62 D-30918 Seelze Sigma Aldrich Logistik GmbH Riedstraße 2 D-89555 Steinheim Solvay Organics GmbH Hans-Böckler-Allee 20 D-30173 Hannover Tazzetti Fluids SRL Corso Europa 600/a I-10088 Volpiano (TO) Valeas SpA Pharmaceuticals Via Vallisneri 10 I-20133 Milano Valvole Aerosol Research Italiana (VARI) SpA — LINDAL Group Italia Via del Pino 10 I-23854 Olginate (LC) VWR ISAS 201, rue Carnot F-94126 Fontenay-sous-Bois